EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Galectin-3-integrin α5β1 phase separation disrupted by advanced glycation end-products impairs diabetic wound healing in rodents

Zhongyu Zhang, Zhengde Zhao, Xiuyi Huang, Lifang Zhou, Xin Jiang, Haoliang Wu, Chenshu Liu, Kan Huang, Jielu Wen, Yunchong Liu, Michelle C Miller, Zihan Zhao und 23 weitere

Nature Communications · 07.08.2025 · 16 (1)

DOI: 10.1038/s41467-025-62320-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature Communications, online erschienen am 07.08.2025. Verfasst von Zhongyu Zhang und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Wound Healing, Diabetic Foot, Galectin 3, Integrin alpha5beta1. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic foot ulcers are severe diabetic complications, and promoting impaired angiogenesis is essential for wound healing. Pro-angiogenic galectin-3 is elevated in diabetic serum and promotes systemic insulin resistance that may impair wound healing. However, the exact role of galectin-3 in the regulation of diabetic wound healing remains unclear. Here, we demonstrate that galectin-3 promotes skin wound healing and angiogenesis via binding to its receptor integrin α5β1, and enhances downstream focal adhesion kinase phosphorylation by forming a liquid-liquid phase separation with integrin α5β1. Under diabetic conditions, aberrant accumulated advanced glycation end-products bind to galectin-3, blocking its interaction with integrin α5β1 and impairing angiogenesis. Topical treatment of recombinant galectin-3 in hydrogels promotes diabetic wound healing in rodents without causing systemic insulin resistance and synergizes with insulin. This study clarifies the binding of galectin-3 to integrin α5β1, instead of advanced glycation end-products, forming phase separation to promote angiogenesis and diabetic wound healing, laying the foundation for local galectin-3 therapy to treat diabetic foot ulcers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound HealingDiabetic FootGalectin 3Integrin alpha5beta1Glycation End Products, AdvancedAngiogenesisInsulin ResistanceFocal Adhesion Protein-Tyrosine KinasesPhosphorylationPhase SeparationHumansMaleAnimalsMiceRatsSkinRats, Sprague-DawleyFemaleMice, Inbred C57BLDiabetes Mellitus, ExperimentalStreptozocinMice, TransgenicGene Knockdown Techniques

Substanzen

Galectin 3Integrin alpha5beta1Focal Adhesion Protein-Tyrosine KinasesGlycation End Products, AdvancedStreptozocin

Autor:innen und Institutionen

  • Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Guangdong Clinical Research Center for Metabolic Diseases, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-sen Universi…
  • Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, Foshan, China.
  • Engineering Research Center of Glycoconjugates Ministry of Education, Jilin Provincial Key Laboratory of Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Ch…
  • Clinical Research Center, Hainan Hospital, Guangdong Provincial Hospital of Chinese Medicine, Haikou, Hainan, China.

Zitieren

APA

Zhang, Z., Zhao, Z., Huang, X., Zhou, L., Jiang, X., Wu, H., Liu, C., Huang, K., Wen, J., Liu, Y., Miller, M. C., Zhao, Z., He, Z., Wang, Y., Liu, S., Huang, L., Yuan, L., Zeng, R., Cen, Z., …, & Chen, S. (2025). Galectin-3-integrin α5β1 phase separation disrupted by advanced glycation end-products impairs diabetic wound healing in rodents. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-62320-w

Vancouver

Zhang Z, Zhao Z, Huang X, Zhou L, Jiang X, Wu H, et al. Galectin-3-integrin α5β1 phase separation disrupted by advanced glycation end-products impairs diabetic wound healing in rodents. Nature Communications. 2025;16(1). doi:10.1038/s41467-025-62320-w

BibTeX
@article{Zhang2025,
  author = {Zhang, Zhongyu and Zhao, Zhengde and Huang, Xiuyi and Zhou, Lifang and Jiang, Xin and Wu, Haoliang and Liu, Chenshu and Huang, Kan and Wen, Jielu and Liu, Yunchong and Miller, Michelle C and Zhao, Zihan and He, Zhen and Wang, Yuxin and Liu, Siyu and Huang, Lijin and Yuan, Lining and Zeng, Renli and Cen, Zhipeng and Chen, Anning and Chen, Yanbo and Zeng, Gang and Liu, Wenzhou and Hong, Xiaosi and Ren, Meng and Yan, Li and Zhang, Yang and Guan, Dongxian and Tian, Xiaoyu and Cai, Weikang and Tai, Guihua and Mayo, Kevin H and Zhou, Yifa and Li, Zilun and Chen, Sifan},
  title = {Galectin-3-integrin α5β1 phase separation disrupted by advanced glycation end-products impairs diabetic wound healing in rodents},
  journal = {Nature Communications},
  year = {2025},
  volume = {16},
  number = {1},
  doi = {10.1038/s41467-025-62320-w}
}
Kostenlos starten →